Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Kissei Pharmaceutical Co ( (JP:4547) ) has shared an update.
Kissei Pharmaceutical Co., Ltd. has completed the disposal of 16,787 treasury shares as restricted stock for its board members and corporate officers. This strategic move, involving a total value of ¥68,490,960, is part of the company’s efforts to align the interests of its leadership with corporate performance, potentially impacting its governance and stakeholder relations.
The most recent analyst rating on (JP:4547) stock is a Hold with a Yen3600.00 price target. To see the full list of analyst forecasts on Kissei Pharmaceutical Co stock, see the JP:4547 Stock Forecast page.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is led by Chairman and CEO Mutsuo Kanzawa.
Average Trading Volume: 91,671
Technical Sentiment Signal: Buy
Current Market Cap: Yen168.9B
Learn more about 4547 stock on TipRanks’ Stock Analysis page.